Anti-Siglec-15 antibody suppresses bone resorption by inhibiting osteoclast multinucleation without attenuating bone formation

Siglec-15-targeting therapy protects against glucocorticoid-induced osteoporosis of growing skeleton in juvenile rats

(2020) Dai Sato et al.   BONE

Direct cell–cell contact between mature osteoblasts and osteoclasts dynamically controls their functions in vivo

(2018) Masayuki Furuya et al.   Nature Communications

Siglec-15-targeting therapy increases bone mass in rats without impairing skeletal growth

(2018) Dai Sato et al.   BONE

Coupling of bone resorption and formation by RANKL reverse signalling

(2018) Yuki Ikebuchi et al.   NATURE

Real-time intravital imaging of pH variation associated with osteoclast activity

(2016) Hiroki Maeda et al.   Nature Chemical Biology

Postmenopausal osteoporosis

(2016) Richard Eastell et al.   Nature Reviews Disease Primers

Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis

(2015) Yusuke Kameda et al.   BONE

Mechanism and Function of Monoclonal Antibodies Targeting Siglec-15 for Therapeutic Inhibition of Osteoclastic Bone Resorption

(2014) Matthew Stuible et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Siglec-15 Regulates Osteoclast Differentiation by Modulating RANKL-Induced Phosphatidylinositol 3-Kinase/Akt and Erk Pathways in Association With Signaling Adaptor DAP12

(2013) Yusuke Kameda et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation

(2013) Sunao Takeshita et al.   JOURNAL OF CLINICAL INVESTIGATION

Impaired osteoclast differentiation and function and mild osteopetrosis development in Siglec-15-deficient mice

(2012) Yoshiharu Hiruma et al.   BONE

Siglec-15 Protein Regulates Formation of Functional Osteoclasts in Concert with DNAX-activating Protein of 12 kDa (DAP12)

(2012) Norihiro Ishida-Kitagawa et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Disorders of Bone Remodeling

(2011) Xu Feng et al.   Annual Review of Pathology-Mechanisms of Disease

Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation

(2011) Yoshiharu Hiruma et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women

(2011) Laura Y. Park-Wyllie   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Epidemiology and pathogenesis of osteonecrosis of the jaw

(2011) Ian R. Reid et al.   Nature Reviews Rheumatology

Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw

(2011) J. Compston   OSTEOPOROSIS INTERNATIONAL

Cellular and Molecular Mechanisms of Bone Remodeling

(2010) Liza J. Raggatt et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis

(2010) Roberto Pacifici   JOURNAL OF BONE AND MINERAL RESEARCH

Long-Term Use of Bisphosphonates in Osteoporosis

(2010) Nelson B. Watts et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Giant Osteoclast Formation and Long-Term Oral Bisphosphonate Therapy

(2009) Robert S. Weinstein et al.   NEW ENGLAND JOURNAL OF MEDICINE